| Financial Year |
September 30 2021 |
| Monetary Funds |
842,646,761.72 |
| Held-for-trading Financial Assets |
50,355,136.99 |
| Notes Receivable |
-- |
| Accounts Receivable |
95,115,432.39 |
| Advances to Suppliers |
399,328,449.28 |
| Other Receivables |
389,004,716.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
876,522,768.66 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
28,142,893.27 |
| Total Current Assets |
2,681,116,159.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
14,316,083.74 |
| Investment Properties |
-- |
| Fixed Assetes |
32,956,161.66 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,399,524.56 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,015,325.93 |
| Deferred Income Tax Assets |
39,711,234.95 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
341,207,191.74 |
| Total Assets |
3,022,323,350.81 |
| Short-Term Loans |
32,427,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
116,437,990.00 |
| Accounts Payable |
113,110,149.26 |
| Accounts Received In Advance |
48,822.32 |
| Employee Compensation Payable |
49,972,040.98 |
| Taxes Payable |
65,392,524.68 |
| Interest Payable |
51,220.31 |
| Dividend Payable |
-- |
| Other payables |
51,873,037.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,453,283.84 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
440,714,848.83 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
31,629.15 |
| Special Payable |
-- |
| Estimatied Liabilities |
34,290,417.26 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
34,322,046.41 |
| Total Liabilities |
475,036,895.24 |
| Paid-In Capital(Or Share Stock) |
402,030,000.00 |
| Capital Surplus |
755,982,166.78 |
| Surplus Reserve |
63,994,561.92 |
| LESS:Treasury Stock |
29,319,000.00 |
| Undistributed Profits |
1,346,641,433.79 |
| Minority Stockholder's Interest |
8,720,690.19 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,538,565,765.38 |
| Owner's Equity（Stockholder's Equity） |
2,547,286,455.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,022,323,350.81 |
